On the public citation graph

Drug repurposing screens and synergistic drug‐combinations for infectious diseases

0 signed · 322 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1007/978-1-4614-7801-0openalex-snapshot

Innovation and marketing in the pharmaceutical industry : emerging practices, research, and policies

inferredcites →https://doi.org/10.1007/978-1-4614-7801-0_2openalex-snapshot

Innovation in the Pharmaceutical Industry: The Process of Drug Discovery and Development

inferredcites →https://doi.org/10.1007/978-81-322-1184-6openalex-snapshot

Omics for Personalized Medicine

inferredcites →https://doi.org/10.1016/j.antiviral.2016.11.017openalex-snapshot

Synergistic drug combination effectively blocks Ebola virus infection

inferredcites →https://doi.org/10.1016/j.atg.2016.04.001openalex-snapshot

Pharmacogenomics for infectious diseases in sub-Saharan Africa: Successes and opportunities

inferredcites →https://doi.org/10.1016/j.cell.2010.11.052openalex-snapshot

Phenotypic Landscape of a Bacterial Cell

inferredcites →https://doi.org/10.1016/j.drudis.2013.07.001openalex-snapshot

Phenotypic screens as a renewed approach for drug discovery

inferredcites →https://doi.org/10.1016/j.drudis.2016.05.015openalex-snapshot

Drug combination therapy increases successful drug repositioning

inferredcites →https://doi.org/10.1016/j.ijantimicag.2007.04.005openalex-snapshot

Impact of infection control interventions and antibiotic use on hospital MRSA: a multivariate interrupted time-series analysis

inferredcites →https://doi.org/10.1016/j.ijantimicag.2017.01.010openalex-snapshot

A randomised, double-blind, phase 3 study comparing the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem for complicated intra-abdominal infections in hospitalised adults in Asia

inferredcites →https://doi.org/10.1016/j.jneuroim.2014.08.615openalex-snapshot

Gold drug auranofin could reduce neuroinflammation by inhibiting microglia cytotoxic secretions and primed respiratory burst

inferredcites →https://doi.org/10.1016/j.lfs.2013.04.005openalex-snapshot

Novel protective properties of auranofin: Inhibition of human astrocyte cytotoxic secretions and direct neuroprotection

inferredcites →https://doi.org/10.1016/s0140-6736(12)61728-0openalex-snapshot

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

inferredcites →https://doi.org/10.1016/s0140-6736(16)00320-2openalex-snapshot

Zika virus and microcephaly: why is this situation a PHEIC?

inferredcites →https://doi.org/10.1021/jm025502xopenalex-snapshot

Nanomolar Inhibitors of Staphylococcus aureus Methionyl tRNA Synthetase with Potent Antibacterial Activity against Gram-Positive Pathogens

inferredcites →https://doi.org/10.1038/36786openalex-snapshot

The complete genome sequence of the Gram-positive bacterium Bacillus subtilis

inferredcites →https://doi.org/10.1038/cddis.2013.473openalex-snapshot

A candidate anti-HIV reservoir compound, auranofin, exerts a selective ‘anti-memory’ effect by exploiting the baseline oxidative status of lymphocytes

inferredcites →https://doi.org/10.1038/emi.2014.88openalex-snapshot

Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs

inferredcites →https://doi.org/10.1038/emi.2016.123openalex-snapshot

Rapid antimicrobial susceptibility test for identification of new therapeutics and drug combinations against multidrug-resistant bacteria

inferredcites →https://doi.org/10.1038/nature12876openalex-snapshot

A molecular marker of artemisinin-resistant Plasmodium falciparum malaria

inferredcites →https://doi.org/10.1038/nature14594openalex-snapshot

Temporal and spatial analysis of the 2014–2015 Ebola virus outbreak in West Africa

inferredcites →https://doi.org/10.1038/nchembio.1911openalex-snapshot

Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA

inferredcites →https://doi.org/10.1038/nchembio.559openalex-snapshot

Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy

inferredcites →https://doi.org/10.1038/nm.2758openalex-snapshot

A high-throughput drug screen for Entamoeba histolytica identifies a new lead and target

inferredcites →https://doi.org/10.1038/nm.4184openalex-snapshot

Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen

inferredcites →https://doi.org/10.1038/nrd.2016.230openalex-snapshot

A comprehensive map of molecular drug targets

inferredcites →https://doi.org/10.1038/nrd3975openalex-snapshot

Platforms for antibiotic discovery

inferredcites →https://doi.org/10.1038/nrd4707openalex-snapshot

Pioneering government-sponsored drug repositioning collaborations: progress and learning

inferredcites →https://doi.org/10.1038/nrd940openalex-snapshot

The future challenges facing the development of new antimicrobial drugs

inferredcites →https://doi.org/10.1038/srep45605openalex-snapshot

Evolution of multi-drug resistant HCV clones from pre-existing resistant-associated variants during direct-acting antiviral therapy determined by third-generation sequencing

inferredcites →https://doi.org/10.1056/nejmoa1212972openalex-snapshot

Fungal Infections Associated with Contaminated Methylprednisolone in Tennessee

inferredcites →https://doi.org/10.1056/nejmoa1314981openalex-snapshot

Spread of Artemisinin Resistance in Plasmodium falciparum Malaria

inferredcites →https://doi.org/10.1056/nejmoa1411677openalex-snapshot

A Case of Severe Ebola Virus Infection Complicated by Gram-Negative Septicemia

inferredcites →https://doi.org/10.1073/pnas.1504022112openalex-snapshot

Auranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasis

inferredcites →https://doi.org/10.1086/647952openalex-snapshot

Antimicrobial Susceptibility Testing: A Review of General Principles and Contemporary Practices

inferredcites →https://doi.org/10.1089/adt.2016.701openalex-snapshot

Validation of a High-Throughput Screening Assay for Identification of Adjunctive and Directly Acting Antimicrobials Targeting Carbapenem-Resistant Enterobacteriaceae

inferredcites →https://doi.org/10.1093/jac/14.5.529openalex-snapshot

Ampicillin combined with sulbactam or metronidazole for single-dose chemoprophylaxis in major gynaecological surgery

inferredcites →https://doi.org/10.1093/jac/46.5.767openalex-snapshot

Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and beta-lactam consumption in Spain (1979-1997)

inferredcites →https://doi.org/10.1093/jac/dkn198openalex-snapshot

Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: a time-series analysis

inferredcites →https://doi.org/10.1093/jac/dkp197openalex-snapshot

In vitro activity of the -lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases

inferredcites →https://doi.org/10.1093/jac/dkt392openalex-snapshot

Carbapenemase-producing Enterobacteriaceae and non-Enterobacteriaceae from animals and the environment: an emerging public health risk of our own making?

inferredcites →https://doi.org/10.1093/jac/dkx113openalex-snapshot

A new rapid resazurin-based microdilution assay for antimicrobial susceptibility testing of Neisseria gonorrhoeae

inferredcites →https://doi.org/10.1093/nar/gkv1037openalex-snapshot

The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands

inferredcites →https://doi.org/10.1097/mjt.0000000000000433openalex-snapshot

New and Emerging Antibiotics for Complicated Intra-Abdominal Infections

inferredcites →https://doi.org/10.1111/bph.13354openalex-snapshot

The Concise Guide to PHARMACOLOGY 2015/16: Enzymes

inferredcites →https://doi.org/10.1111/bph.13895openalex-snapshot

Drug repurposing screens and synergistic drug‐combinations for infectious diseases

inferredcites →https://doi.org/10.1111/j.1365-2958.1995.tb02309.xopenalex-snapshot

Open complex formation by Escherichia coli RNA polymerase: the mechanism of polymerase‐induced strand separation of double helical DNA

inferredcites →https://doi.org/10.1111/j.1469-0691.2006.01528.xopenalex-snapshot

Impact of antibiotic restrictions: the pharmaceutical perspective

inferredcites →https://doi.org/10.1126/science.135.3508.1067openalex-snapshot

Synergism between Streptomycin and Penicillin: A Proposed Mechanism

inferredcites →https://doi.org/10.1126/scitranslmed.3001862openalex-snapshot

The NCGC Pharmaceutical Collection: A Comprehensive Resource of Clinically Approved Drugs Enabling Repurposing and Chemical Genomics

inferredcites →https://doi.org/10.1126/scitranslmed.3004129openalex-snapshot

Tracking a Hospital Outbreak of Carbapenem-Resistant Klebsiella pneumoniae with Whole-Genome Sequencing

inferredcites →https://doi.org/10.1126/scitranslmed.3009845openalex-snapshot

Single-molecule sequencing to track plasmid diversity of hospital-associated carbapenemase-producing Enterobacteriaceae

inferredcites →https://doi.org/10.1126/scitranslmed.3009940openalex-snapshot

Prediction of resistance development against drug combinations by collateral responses to component drugs

inferredcites →https://doi.org/10.1126/scitranslmed.3010286openalex-snapshot

Repurposing of the antihistamine chlorcyclizine and related compounds for treatment of hepatitis C virus infection

inferredcites →https://doi.org/10.1128/aac.13.3.389openalex-snapshot

In vitro study of clavulanic acid in combination with penicillin, amoxycillin, and carbenicillin

inferredcites →https://doi.org/10.1128/aac.17.4.615openalex-snapshot

CP-45,899 in combination with penicillin or ampicillin against penicillin-resistant Staphylococcus, Haemophilus influenzae, and Bacteroides

inferredcites →https://doi.org/10.1128/aac.24.5.679openalex-snapshot

Amoxicillin combined with clavulanic acid for the treatment of soft tissue infections in children

inferredcites →https://doi.org/10.1128/aac.29.6.980openalex-snapshot

Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined beta-lactamase-producing aerobic gram-negative bacilli

inferredcites →https://doi.org/10.1128/aac.35.7.1348openalex-snapshot

Pneumocystis carinii dihydrofolate reductase used to screen potential antipneumocystis drugs

inferredcites →https://doi.org/10.1128/aac.46.10.3118-3124.2002openalex-snapshot

Discovery of a Novel and Potent Class of FabI-Directed Antibacterial Agents

inferredcites →https://doi.org/10.1128/aac.46.11.3343-3347.2002openalex-snapshot

Defining and Combating the Mechanisms of Triclosan Resistance in Clinical Isolates ofStaphylococcus aureus

inferredcites →https://doi.org/10.1128/jcm.00313-13openalex-snapshot

Next-Generation Antimicrobial Susceptibility Testing

inferredcites →https://doi.org/10.1128/jcm.00932-16openalex-snapshot

Verification of an Automated, Digital Dispensing Platform for At-Will Broth Microdilution-Based Antimicrobial Susceptibility Testing

inferredcites →https://doi.org/10.1128/jcm.01643-15openalex-snapshot

Clinical Performance of a Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry Method for Detection of Certain bla KPC -Containing Plasmids

inferredcites →https://doi.org/10.1128/jcm.01714-16openalex-snapshot

Commentary: Next-Generation Epidemiology: Using Real-Time Core Genome Multilocus Sequence Typing To Support Infection Control Policy

inferredcites →https://doi.org/10.1128/mbio.00765-13openalex-snapshot

Estrogen Receptor Antagonists Are Anti-Cryptococcal Agents That Directly Bind EF Hand Proteins and Synergize with FluconazoleIn Vivo

inferredcites →https://doi.org/10.1136/bmj.i5978openalex-snapshot

Hospital transmittedCandida aurisinfections confirmed in the US

inferredcites →https://doi.org/10.1158/0008-5472.can-13-2033openalex-snapshot

Auranofin Induces Lethal Oxidative and Endoplasmic Reticulum Stress and Exerts Potent Preclinical Activity against Chronic Lymphocytic Leukemia

inferredcites →https://doi.org/10.1186/cc9997openalex-snapshot

New treatment options against gram-negative organisms

inferredcites →https://doi.org/10.1186/gm394openalex-snapshot

Pharmacogenomics: a key component of personalized therapy

inferredcites →https://doi.org/10.1186/preaccept-6556009101270526openalex-snapshot

Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study

inferredcites →https://doi.org/10.1371/journal.ppat.0030018openalex-snapshot

Antifungal Chemical Compounds Identified Using a C. elegans Pathogenicity Assay

inferredcites →https://doi.org/10.2460/ajvr.1997.58.07.749openalex-snapshot

Growth of Pasteurella haemolytica and production of its leukotoxin in semi-defined media

inferredcites →https://doi.org/10.7554/elife.09744openalex-snapshot

The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasis

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4805413openalex-extracted

Systematic Analysis of Traditional Chinese Medicine Prescriptions Provides New Insights into Drug Combination Therapy for Pox

inferred← citeshttps://doi.org/10.1002/9781394466573.ch15openalex-snapshot

Experimental Models for Drug Repurposing in Viral Hepatitis

inferred← citeshttps://doi.org/10.1002/adhm.202101465openalex-snapshot

Polymyxin B‐Triggered Assembly of Peptide Hydrogels for Localized and Sustained Release of Combined Antimicrobial Therapy

inferred← citeshttps://doi.org/10.1002/advs.202100681openalex-snapshot

Diclofenac Resensitizes Methicillin‐Resistant Staphylococcus aureus to β‐Lactams and Prevents Implant Infections

inferred← citeshttps://doi.org/10.1002/ardp.202000168openalex-snapshot

Reprogramming of antibiotics to combat antimicrobial resistance

inferred← citeshttps://doi.org/10.1002/btpr.3110openalex-snapshot

Computational drug repurposing study of the RNA binding domain of SARS‐CoV ‐2 nucleocapsid protein with antiviral agents

inferred← citeshttps://doi.org/10.1002/cmdc.202200440openalex-snapshot

Recent Drug Development and Medicinal Chemistry Approaches for the Treatment of SARS‐CoV‐2 Infection and COVID‐19

inferred← citeshttps://doi.org/10.1002/ctd2.317openalex-snapshot

Deep learning for predicting synergistic drug combinations: State‐of‐the‐arts and future directions

inferred← citeshttps://doi.org/10.1002/ddr.21640openalex-snapshot

Selected pharmacotherapy agents as antiproliferative and anti‐inflammatory compounds

inferred← citeshttps://doi.org/10.1002/ddr.21746openalex-snapshot

Phytochemical conjugation as a potential semisynthetic approach toward reactive and reuse of obsolete sulfonamides against pathogenic bacteria

inferred← citeshttps://doi.org/10.1002/mbo3.70317openalex-snapshot

Host–Pathogen Dual Targeting With Repurposed Drugs Identifies a Synergistic Therapy for Intracellular Staphylococcus aureus

inferred← citeshttps://doi.org/10.1002/mbo3.824openalex-snapshot

Identification of Asparagopsis armata‐associated bacteria and characterization of their bioactive potential

inferred← citeshttps://doi.org/10.1002/minf.202000012openalex-snapshot

Drug Re‐positioning Studies for Novel HIV‐1 Inhibitors Using Binary QSAR Models and Multi‐target‐driven In Silico Studies

inferred← citeshttps://doi.org/10.1002/minf.202100062openalex-snapshot

Screening of Clinically Approved and Investigation Drugs as Potential Inhibitors of SARS‐CoV‐2: A Combinedin silicoandin vitroStudy

inferred← citeshttps://doi.org/10.1002/open.202100248openalex-snapshot

Identification of SARS‐CoV‐2 Papain‐like Protease (PLpro) Inhibitors Using Combined Computational Approach**

inferred← citeshttps://doi.org/10.1002/psp4.70329openalex-snapshot

Deciphering the Mechanisms of Statin–Ezetimibe Drug Combinations Using Boolean Logical Modeling and Transcriptomic Data

inferred← citeshttps://doi.org/10.1002/ptr.7039openalex-snapshot

Medicinal plants: Treasure for antiviral drug discovery

inferred← citeshttps://doi.org/10.1007/978-3-030-51862-2_12openalex-snapshot

Computational Modeling in Virus Infections and Virtual Screening, Docking, and Molecular Dynamics in Drug Design

inferred← citeshttps://doi.org/10.1007/978-3-030-72834-2_15openalex-snapshot

Siddha Medicine and Computer Modeling: A Treasure for SARS-CoV-2 Treatment

inferred← citeshttps://doi.org/10.1007/978-3-031-33871-7_4openalex-snapshot

Computational Modeling in the Development of Antiviral Agents

inferred← citeshttps://doi.org/10.1007/978-3-031-65986-7_3openalex-snapshot

Deciphering Microbial Regulation of Heterogeneity and Drug Adaptation with Meta-transcriptomics and Other System-Level Tools

inferred← citeshttps://doi.org/10.1007/978-981-16-9232-1_5openalex-snapshot

Genomic Approaches for Drug Repositioning

inferred← citeshttps://doi.org/10.1007/978-981-19-5399-6_16openalex-snapshot

Repurposing of Drugs for the Treatment of Microbial Diseases

inferred← citeshttps://doi.org/10.1007/978-981-19-9605-4_13openalex-snapshot

Recent Advances in the Treatment of Parasitic Diseases: Current Status and Future

inferred← citeshttps://doi.org/10.1007/978-981-95-4522-3_2openalex-snapshot

Drug Repurposing: Exploring Newer Therapeutic Potentials

inferred← citeshttps://doi.org/10.1007/s00044-018-02286-1openalex-snapshot

Dengue virus replication inhibition by dibenzothiepin derivatives

inferred← citeshttps://doi.org/10.1007/s00044-022-02960-5openalex-snapshot

Combination with a FtsZ inhibitor potentiates the in vivo efficacy of oxacillin against methicillin-resistant Staphylococcus aureus

inferred← citeshttps://doi.org/10.1007/s00203-025-04518-6openalex-snapshot

Novel strategies for combating colistin-resistant isolates: a review

inferred← citeshttps://doi.org/10.1007/s00284-023-03242-yopenalex-snapshot

Repositioning of Benzodiazepine Drugs and Synergistic Effect with Ciprofloxacin Against ESKAPE Pathogens

inferred← citeshttps://doi.org/10.1007/s00772-019-00573-8openalex-snapshot

„Drug repurposing“ und „orphan drug usage“

inferred← citeshttps://doi.org/10.1007/s10096-020-03881-0openalex-snapshot

Pentamidine sensitizes FDA-approved non-antibiotics for the inhibition of multidrug-resistant Gram-negative pathogens

inferred← citeshttps://doi.org/10.1007/s11274-021-03016-3openalex-snapshot

Repositioning of antidepressant drugs and synergistic effect with ciprofloxacin against multidrug-resistant bacteria

inferred← citeshttps://doi.org/10.1007/s11426-024-2228-4openalex-snapshot

Chemical biology investigation of a triple-action, smart-decomposition antimicrobial booster based-combination therapy against “ESKAPE” pathogens

inferred← citeshttps://doi.org/10.1007/s12602-026-10928-9openalex-snapshot

Antimicrobial Armageddon: The Professional Guide to Conquering Antibiotic Resistance

inferred← citeshttps://doi.org/10.1007/s40262-020-00892-0openalex-snapshot

Preclinical Pharmacokinetic/Pharmacodynamic Studies and Clinical Trials in the Drug Development Process of EMA-Approved Antibacterial Agents: A Review

inferred← citeshttps://doi.org/10.1016/b978-0-12-801238-3.11569-7openalex-snapshot

Drug Combination Modeling

inferred← citeshttps://doi.org/10.1016/b978-0-12-814692-7.00004-8openalex-snapshot

Future Nontuberculous Mycobacteria DST and Therapeutic Interventions

inferred← citeshttps://doi.org/10.1016/b978-0-12-816125-8.00005-5openalex-snapshot

Repurposed Molecules: A New Hope in Tackling Neglected Infectious Diseases

inferred← citeshttps://doi.org/10.1016/b978-0-12-816125-8.00015-8openalex-snapshot

Application of In Silico Drug Repurposing in Infectious Diseases

inferred← citeshttps://doi.org/10.1016/b978-0-12-816125-8.00026-2openalex-snapshot

In Silico Drug Repurposing for MDR Bacteria: Opportunities and Challenges

inferred← citeshttps://doi.org/10.1016/b978-0-12-819668-7.00014-2openalex-snapshot

Nanotechnological approaches in cancer

inferred← citeshttps://doi.org/10.1016/b978-0-12-820054-4.00002-1openalex-snapshot

Therapeutic Efficacy of Antibiotics in the Treatment of Chronic Diseases

inferred← citeshttps://doi.org/10.1016/b978-0-12-820472-6.00058-xopenalex-snapshot

Drug Combinations

inferred← citeshttps://doi.org/10.1016/b978-0-323-88480-8.00003-0openalex-snapshot

Application of synthetic products against pathogenic fungal biofilm development with special reference to combinational approaches

inferred← citeshttps://doi.org/10.1016/b978-0-323-91814-5.00018-0openalex-snapshot

Strategies for delivery of antiviral agents

inferred← citeshttps://doi.org/10.1016/b978-0-323-95578-2.00010-8openalex-snapshot

In silico approaches in drug discovery for SARS-CoV-2

inferred← citeshttps://doi.org/10.1016/bs.pmbts.2024.03.021openalex-snapshot

Novel strategies for drug repurposing

inferred← citeshttps://doi.org/10.1016/bs.pmbts.2024.05.001openalex-snapshot

Drug repurposing for parasitic protozoan diseases

inferred← citeshttps://doi.org/10.1016/j.actatropica.2022.106564openalex-snapshot

Multi-stage transcriptome profiling of the neglected food-borne echinostome Artyfechinostomum sufrartyfex reveal potential diagnostic and drug targets

inferred← citeshttps://doi.org/10.1016/j.addr.2025.115661openalex-snapshot

Predicting population dynamics of antimicrobial resistance using mechanistic modeling and machine learning

inferred← citeshttps://doi.org/10.1016/j.bioactmat.2021.11.019openalex-snapshot

Felodipine enhances aminoglycosides efficacy against implant infections caused by methicillin-resistant Staphylococcus aureus, persisters and biofilms

inferred← citeshttps://doi.org/10.1016/j.biopha.2021.112274openalex-snapshot

ERα-independent NRF2-mediated immunoregulatory activity of tamoxifen

inferred← citeshttps://doi.org/10.1016/j.bjid.2018.05.007openalex-snapshot

Drug repositioning, a new alternative in infectious diseases

inferred← citeshttps://doi.org/10.1016/j.cbi.2020.109298openalex-snapshot

Race to arsenal COVID-19 therapeutics: Current alarming status and future directions

inferred← citeshttps://doi.org/10.1016/j.clinthera.2019.08.014openalex-snapshot

Drug Repurposing Identifies New Promising Treatment Options for Invasive Fungal Diseases

inferred← citeshttps://doi.org/10.1016/j.compbiolchem.2024.108273openalex-snapshot

Autoencoder-based drug synergy framework for malignant diseases

inferred← citeshttps://doi.org/10.1016/j.compbiomed.2021.104856openalex-snapshot

Molecular descriptor analysis of approved drugs using unsupervised learning for drug repurposing

inferred← citeshttps://doi.org/10.1016/j.csbj.2021.12.039openalex-snapshot

Comparative metabolomics revealed key pathways associated with the synergistic killing of multidrug-resistant Klebsiella pneumoniae by a bacteriophage-polymyxin combination

inferred← citeshttps://doi.org/10.1016/j.drudis.2018.08.010openalex-snapshot

Advancing precision medicine with personalized drug screening

inferred← citeshttps://doi.org/10.1016/j.drudis.2022.02.010openalex-snapshot

Repurposing of the gold drug auranofin and a review of its derivatives as antibacterial therapeutics

inferred← citeshttps://doi.org/10.1016/j.drudis.2022.04.006openalex-snapshot

Machine learning to design antimicrobial combination therapies: Promises and pitfalls

inferred← citeshttps://doi.org/10.1016/j.ebiom.2019.04.029openalex-snapshot

Phenotypic screening of nonsteroidal anti-inflammatory drugs identified mefenamic acid as a drug for the treatment of schistosomiasis

inferred← citeshttps://doi.org/10.1016/j.ejps.2020.105522openalex-snapshot

Emerging strategies on in silico drug development against COVID-19: challenges and opportunities

inferred← citeshttps://doi.org/10.1016/j.ijantimicag.2020.105969openalex-snapshot

Drug repositioning is an alternative for the treatment of coronavirus COVID-19

inferred← citeshttps://doi.org/10.1016/j.ijantimicag.2021.106380openalex-snapshot

Repositioning of non-antibiotic drugs as an alternative to microbial resistance: a systematic review

inferred← citeshttps://doi.org/10.1016/j.ijantimicag.2024.107338openalex-snapshot

Isobavachalcone enhances sensitivity of colistin-resistant Klebsiella pneumoniae: In vitro and in vivo proof-of-concept studies

inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2024.138859openalex-snapshot

A multi-functional oxidative konjac glucomannan/ε-poly-l-lysine hydrogel with antibacterial, haemostatic, and chronic diabetic wound-treating properties

inferred← citeshttps://doi.org/10.1016/j.ijid.2020.02.018openalex-snapshot

Discovery and development of safe-in-man broad-spectrum antiviral agents

inferred← citeshttps://doi.org/10.1016/j.ijpddr.2017.11.004openalex-snapshot

An automated high-throughput system for phenotypic screening of chemical libraries on C. elegans and parasitic nematodes

inferred← citeshttps://doi.org/10.1016/j.ijpharm.2025.125385openalex-snapshot

A new era of psoriasis treatment: Drug repurposing through the lens of nanotechnology and machine learning

inferred← citeshttps://doi.org/10.1016/j.jep.2024.118842openalex-snapshot

Systematic analysis of traditional Chinese medicine prescriptions provides new insights into drug combination therapy for pox

inferred← citeshttps://doi.org/10.1016/j.jep.2026.121753openalex-snapshot

Immunomodulatory effect of traditional Chinese medicine in infectious diseases

inferred← citeshttps://doi.org/10.1016/j.jii.2024.100562openalex-snapshot

Industry 4.0 technologies adoption for digital transition in drug discovery and development: A review

inferred← citeshttps://doi.org/10.1016/j.jsbmb.2024.106609openalex-snapshot

Latent Class Analysis Reveals, in patient profiles, COVID-19–related better prognosis by calcifediol treatment than glucocorticoids

inferred← citeshttps://doi.org/10.1016/j.medidd.2022.100140openalex-snapshot

Current status of antihistamine drugs repurposing for infectious diseases

inferred← citeshttps://doi.org/10.1016/j.molstruc.2020.129449openalex-snapshot

Fenoterol and dobutamine as SARS-CoV-2 main protease inhibitors: A virtual screening study

inferred← citeshttps://doi.org/10.1016/j.phymed.2024.155421openalex-snapshot

Gramine sensitizes Klebsiella pneumoniae to tigecycline killing

inferred← citeshttps://doi.org/10.1016/j.talanta.2019.01.039openalex-snapshot

A simple and rapid colorimetric bacteria detection method based on bacterial inhibition of glucose oxidase-catalyzed reaction

inferred← citeshttps://doi.org/10.1016/j.tim.2018.04.004openalex-snapshot

Drug Repurposing for Viral Infectious Diseases: How Far Are We?

inferred← citeshttps://doi.org/10.1016/j.tranon.2018.06.002openalex-snapshot

Small Molecules Identified from a Quantitative Drug Combinational Screen Resensitize Cisplatin's Response in Drug-Resistant Ovarian Cancer Cells

inferred← citeshttps://doi.org/10.1016/j.tube.2023.102363openalex-snapshot

Isoniazid-N-acylhydrazones as promising compounds for the anti-tuberculosis treatment

inferred← citeshttps://doi.org/10.1016/j.xcrp.2023.101520openalex-snapshot

Integrating multi-modal deep learning on knowledge graph for the discovery of synergistic drug combinations against infectious diseases

inferred← citeshttps://doi.org/10.1016/j.xphs.2023.04.004openalex-snapshot

Review on 505(b)(2) Drug Products Approved by USFDA from 2010 to 2020 Emphasizing Intellectual Property and Regulatory Considerations for Reformulations and New Combinations

inferred← citeshttps://doi.org/10.1021/acs.analchem.9b02690openalex-snapshot

Overcoming Multidrug-Resistance in Bacteria with a Two-Step Process to Repurpose and Recombine Established Drugs

inferred← citeshttps://doi.org/10.1021/acs.chemmater.5c00958openalex-snapshot

Near-Infrared Light-Triggered Bacterial Eradication by Different Morphologies of NH2-MIL-101(Fe)@Ag

inferred← citeshttps://doi.org/10.1021/acs.jafc.2c00038openalex-snapshot

Repurposing of Marine Raw Materials in the Formulation of Innovative Plant Protection Products

inferred← citeshttps://doi.org/10.1021/acs.jafc.2c06991openalex-snapshot

Gallic Acid Restores the Sulfonamide Sensitivity of Multidrug-Resistant Streptococcus suis via Polypharmaceology Mechanism

inferred← citeshttps://doi.org/10.1021/acs.jcim.3c00709openalex-snapshot

AttenSyn: An Attention-Based Deep Graph Neural Network for Anticancer Synergistic Drug Combination Prediction

inferred← citeshttps://doi.org/10.1021/acs.jcim.4c00003openalex-snapshot

HANSynergy: Heterogeneous Graph Attention Network for Drug Synergy Prediction

inferred← citeshttps://doi.org/10.1021/acs.jcim.4c01101openalex-snapshot

DDSBC: A Stacking Ensemble Classifier-Based Approach for Breast Cancer Drug-Pair Cell Synergy Prediction

inferred← citeshttps://doi.org/10.1021/acs.jmedchem.9b00550openalex-snapshot

Synthesis and Structure–Activity Relationship Study of Antimicrobial Auranofin against ESKAPE Pathogens

inferred← citeshttps://doi.org/10.1021/acschembio.2c00613openalex-snapshot

Cooperative Membrane Damage as a Mechanism for Pentamidine–Antibiotic Mutual Sensitization

inferred← citeshttps://doi.org/10.1021/acscombsci.8b00088openalex-snapshot

Combating a Master Manipulator: Staphylococcus aureus Immunomodulatory Molecules as Targets for Combinatorial Drug Discovery

inferred← citeshttps://doi.org/10.1021/acsomega.5c00996openalex-snapshot

Amiodarone and Ravuconazole Combination Potentiates Chemotherapy against Drug-Resistant Trypanosoma cruzi Strains

inferred← citeshttps://doi.org/10.1021/acsomega.6c03899openalex-snapshot

Synergistic Ionic Liquid-Antibiotic Combination as a Strategy against Methicillin-Resistant Staphylococcus aureus (MRSA)

inferred← citeshttps://doi.org/10.1021/acsptsci.0c00112openalex-snapshot

Identifying SARS-CoV‑2 Entry Inhibitors through Drug Repurposing Screens of SARS‑S and MERS‑S Pseudotyped Particles

inferred← citeshttps://doi.org/10.1038/s41429-023-00594-2openalex-snapshot

Drug repurposing strategy II: from approved drugs to agri-fungicide leads

inferred← citeshttps://doi.org/10.1038/s41467-019-09186-xopenalex-snapshot

Network-based prediction of drug combinations

inferred← citeshttps://doi.org/10.1038/s41598-022-08272-3openalex-snapshot

Functionalization of an extended-gate field-effect transistor (EGFET) for bacteria detection

inferred← citeshttps://doi.org/10.1038/s41598-022-10393-8openalex-snapshot

Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli

inferred← citeshttps://doi.org/10.1038/s41598-025-87146-wopenalex-snapshot

Domperidone inhibits dengue virus infection by targeting the viral envelope protein and nonstructural protein 1

inferred← citeshttps://doi.org/10.1038/s41598-025-99741-yopenalex-snapshot

Synergistic mechanism of olaparib and cisplatin on breast cancer elucidated by network pharmacology

inferred← citeshttps://doi.org/10.1039/9781788016858-00232openalex-snapshot

Repurposing Approved Drugs to Block Highly Pathogenic Emerging Viruses

inferred← citeshttps://doi.org/10.1039/d4md00449copenalex-snapshot

Understanding the mechanisms of antimicrobial resistance and potential therapeutic approaches against the Gram-negative pathogen Acinetobacter baumannii

inferred← citeshttps://doi.org/10.1039/d5ra07169kopenalex-snapshot

Interleaving-twisted nanoarchitectured porous organic polymer synergizes photoactivity enhancement and nanozyme-powered microenvironment remodeling for advanced infected wound therapy

inferred← citeshttps://doi.org/10.1042/bcj20210198openalex-snapshot

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp14/nsp10 exoribonuclease

inferred← citeshttps://doi.org/10.1042/bcj20210199openalex-snapshot

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp15 endoribonuclease

inferred← citeshttps://doi.org/10.1042/bcj20210201openalex-snapshot

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicase

inferred← citeshttps://doi.org/10.1080/07391102.2022.2091658openalex-snapshot

A new approach used in docking study for predicting the combination drug efficacy in EML4-ALK target of NSCLC

inferred← citeshttps://doi.org/10.1080/08927014.2025.2486250openalex-snapshot

Effect of promethazine against Staphylococcus aureus and its preventive action in the formation of biofilms on silicone catheters

inferred← citeshttps://doi.org/10.1080/13543776.2018.1503252openalex-snapshot

Future perspectives for cryptococcosis treatment

inferred← citeshttps://doi.org/10.1080/17425247.2021.1886074openalex-snapshot

Inhaled fixed-dose combination powders for the treatment of respiratory infections

inferred← citeshttps://doi.org/10.1089/jamp.2022.0062openalex-snapshot

Safety, Tolerability, and Pharmacokinetics of Nebulized Hydroxychloroquine: A Pilot Study in Healthy Volunteers

inferred← citeshttps://doi.org/10.1093/bib/bbab390openalex-snapshot

DeepDDS: deep graph neural network with attention mechanism to predict synergistic drug combinations

inferred← citeshttps://doi.org/10.1093/bib/bbad285openalex-snapshot

A model-agnostic framework to enhance knowledge graph-based drug combination prediction with drug–drug interaction data and supervised contrastive learning

inferred← citeshttps://doi.org/10.1093/bib/bbag157openalex-snapshot

TensoGraph: a tensor–transformer framework for global–local drug synergy prediction on heterogeneous graphs

inferred← citeshttps://doi.org/10.1093/bioinformatics/btac538openalex-snapshot

Multidrug representation learning based on pretraining model and molecular graph for drug interaction and combination prediction

inferred← citeshttps://doi.org/10.1093/icc/dtac023openalex-snapshot

Functional diversification and exaptation: the emergence of new drug uses in the pharma industry

inferred← citeshttps://doi.org/10.1093/lambio/ovad119openalex-snapshot

Antibiofilm activity of promethazine, deferiprone, and Manuka honey in an ex vivo wound model

inferred← citeshttps://doi.org/10.1093/mmy/myac039openalex-snapshot

Biofilm and hyphal inhibitory synergistic effects of phytoactives piperine and cinnamaldehyde against Candida albicans

inferred← citeshttps://doi.org/10.1093/nar/gkaa1272openalex-snapshot

Network controllability-based algorithm to target personalized driver genes for discovering combinatorial drugs of individual patients

inferred← citeshttps://doi.org/10.1097/mjt.0000000000001022openalex-snapshot

Antimicrobial and Antineoplastic Properties of Sertraline

inferred← citeshttps://doi.org/10.1097/mjt.0000000000001122openalex-snapshot

Amlodipine Repositioning: Scientific Studies and Synergistic Effects

inferred← citeshttps://doi.org/10.1101/2020.05.12.091165openalex-snapshot

Potential antiviral options against SARS-CoV-2 infection

inferred← citeshttps://doi.org/10.1101/2021.04.07.438812openalex-snapshot

Identifying SARS-CoV-2 Antiviral Compounds by Screening for Small Molecule Inhibitors of Nsp14/nsp10 Exoribonuclease

inferred← citeshttps://doi.org/10.1101/2021.04.12.439341openalex-snapshot

Cannabidiol (CBD) repurposing as antibacterial: promising therapy of CBD plus polymyxin B against superbugs

inferred← citeshttps://doi.org/10.1101/2022.05.16.491802openalex-snapshot

Novel synergistic combinations of last-line antibiotics and FDA-approved drugs against Klebsiella pneumoniae revealed by in vitro synergy screenings

inferred← citeshttps://doi.org/10.1101/2025.06.02.657361openalex-snapshot

Integrating Multimodal Data for a Comprehensive Knowledge Graph to Advance Infectious Disease Research

inferred← citeshttps://doi.org/10.1101/571620openalex-snapshot

A novel network controllability algorithm to target personalized driver genes for discovering combinational drugs of individual cancer patient

inferred← citeshttps://doi.org/10.1109/bibm62325.2024.10822303openalex-snapshot

Drug Combination Side Effect Prediction Based on Polypharmacy Network and GraphSAGE Algorithm

inferred← citeshttps://doi.org/10.1109/embc58623.2025.11253169openalex-snapshot

PMDSynergy: Pre-training-based multi-dimensional fusion model for cancer drug synergy prediction

inferred← citeshttps://doi.org/10.1109/jbhi.2024.3421916openalex-snapshot

MDNNSyn: A Multi-Modal Deep Learning Framework for Drug Synergy Prediction

inferred← citeshttps://doi.org/10.1111/apm.13014openalex-snapshot

The first wide‐scale drug repurposing screen using the Prestwick Chemical Library (1200 bioactive molecules) against Neisseria gonorrhoeae identifies high in vitro activity of auranofin and many additional drugs

inferred← citeshttps://doi.org/10.1111/bph.14081openalex-snapshot

Inventing new therapies without reinventing the wheel: the power of drug repurposing

inferred← citeshttps://doi.org/10.1111/cbdd.13453openalex-snapshot

Improving inverse docking target identification with Z‐score selection

inferred← citeshttps://doi.org/10.1111/cbdd.14345openalex-snapshot

Arylidene and amino spacer‐linked rhodanine‐quinoline hybrids as upgraded antimicrobial agents

inferred← citeshttps://doi.org/10.1111/jam.14312openalex-snapshot

Repurposing auranofin to combat uropathogenic Escherichia coli biofilms

inferred← citeshttps://doi.org/10.1124/jpet.120.000123openalex-snapshot

Drug Discovery Strategies for SARS-CoV-2

inferred← citeshttps://doi.org/10.1124/pharmrev.124.000951openalex-snapshot

Drug-Drug Interactions and Synergy: From Pharmacological Models to Clinical Application

inferred← citeshttps://doi.org/10.1128/aac.00609-19openalex-snapshot

The Repurposed Drug Disulfiram Inhibits Urease and Aldehyde Dehydrogenase and Prevents In Vitro Growth of the Oomycete Pythium insidiosum

inferred← citeshttps://doi.org/10.1128/aac.00878-21openalex-snapshot

Adaptive Responses of Pseudomonas aeruginosa to Treatment with Antibiotics

inferred← citeshttps://doi.org/10.1128/aac.01015-23openalex-snapshot

Two-way pharmacodynamic modeling of drug combinations and its application to pairs of repurposed Ebola and SARS-CoV-2 agents

inferred← citeshttps://doi.org/10.1128/aac.01084-18openalex-snapshot

Screening a Repurposing Library for Inhibitors of Multidrug-Resistant Candida auris Identifies Ebselen as a Repositionable Candidate for Antifungal Drug Development

inferred← citeshttps://doi.org/10.1128/aac.01208-19openalex-snapshot

Promethazine Exhibits Antiparasitic Properties In Vitro and Reduces Worm Burden, Egg Production, Hepatomegaly, and Splenomegaly in a Schistosomiasis Animal Model

inferred← citeshttps://doi.org/10.1128/aac.01307-22openalex-snapshot

High-Resolution Bacterial Cytological Profiling Reveals Intrapopulation Morphological Variations upon Antibiotic Exposure

inferred← citeshttps://doi.org/10.1128/mbio.02726-21openalex-snapshot

Ceragenins and Antimicrobial Peptides Kill Bacteria through Distinct Mechanisms

inferred← citeshttps://doi.org/10.1128/msystems.00233-21openalex-snapshot

Identification and Development of Therapeutics for COVID-19

inferred← citeshttps://doi.org/10.1128/msystems.01026-23openalex-snapshot

Repurposing of the antimalarial agent tafenoquine to combat MRSA

inferred← citeshttps://doi.org/10.1128/spectrum.03469-22openalex-snapshot

Mechanism of Action of Isopropoxy Benzene Guanidine against Multidrug-Resistant Pathogens

inferred← citeshttps://doi.org/10.1128/spectrum.04052-22openalex-snapshot

Flufenamic Acid, a Promising Agent for the Sensitization of Colistin-Resistant Gram-Negative Bacteria to Colistin

inferred← citeshttps://doi.org/10.1155/2024/6635476openalex-snapshot

Identification of the Plausible Drug Target via Network/Genome Analysis and Its Molecular Interaction Studies Against Multidrug Resistance Bacterial Pathogens

inferred← citeshttps://doi.org/10.11606/d.60.2022.tde-21032022-082714openalex-snapshot

Atividade antibacteriana do canabidiol: potencial reposicionamento e combinação com polimixina B contra bactérias multidroga-resistentes

inferred← citeshttps://doi.org/10.1177/1535370218755659openalex-snapshot

Better living through chemistry: Addressing emerging antibiotic resistance

inferred← citeshttps://doi.org/10.1186/s12951-024-02706-yopenalex-snapshot

Infection microenvironment-triggered nanoparticles eradicate MRSA by thermally amplified chemodynamic therapy and M1 macrophage

inferred← citeshttps://doi.org/10.1186/s13321-024-00859-4openalex-snapshot

piscesCSM: prediction of anticancer synergistic drug combinations

inferred← citeshttps://doi.org/10.1186/s13568-021-01272-yopenalex-snapshot

Antimicrobial compounds were isolated from the secondary metabolites of Gordonia, a resident of intestinal tract of Periplaneta americana

inferred← citeshttps://doi.org/10.1186/s13568-024-01660-0openalex-snapshot

Drug repurposing: insights into the antimicrobial effects of AKBA against MRSA

inferred← citeshttps://doi.org/10.1186/s41231-019-0050-7openalex-snapshot

Lost in translation: the valley of death across preclinical and clinical divide – identification of problems and overcoming obstacles

inferred← citeshttps://doi.org/10.1371/journal.pcbi.1010951openalex-snapshot

MGAE-DC: Predicting the synergistic effects of drug combinations through multi-channel graph autoencoders

inferred← citeshttps://doi.org/10.1371/journal.pcbi.1013619openalex-snapshot

Robust prediction of drug combination side effects in realistic settings

inferred← citeshttps://doi.org/10.1371/journal.pone.0257784openalex-snapshot

Drug repurposing for COVID-19 based on an integrative meta-analysis of SARS-CoV-2 induced gene signature in human airway epithelium

inferred← citeshttps://doi.org/10.1371/journal.pone.0326632openalex-snapshot

Genome-wide identification and in-silico characterization of phytopathogenic Taf14 gene in Fusarium oxysporum fungus, and fungicide repurposing

inferred← citeshttps://doi.org/10.14293/s2199-1006.1.sor-.pppt99i.v1openalex-snapshot

Investigation of N Terminal Domain of SARS CoV 2 Nucleocapsid Protein with Antiviral Compounds Based on Molecular Modeling Approach

inferred← citeshttps://doi.org/10.14719/pst.2855openalex-snapshot

Evaluation of antibacterial and antifungal activities of Pistacia atlantica and Pistacia khinjuk

inferred← citeshttps://doi.org/10.1590/s2175-97902019000418089openalex-snapshot

Synergistic effect of sertraline and disulfiram against multidrug resistant bacteria as a new alternative to drug repositioning

inferred← citeshttps://doi.org/10.16891/2317-434x.v8.e3.a2020.pp636-648openalex-snapshot

ESTUDO IN SILICO DO POTENCIAL DE FÁRMACOS AZÓLICOS SOBRE SARS-CoV-2: UMA ABORDAGEM QUÍMICA-MEDICINAL

inferred← citeshttps://doi.org/10.17760/d20317952openalex-snapshot

Preparation of nanoparticles by green synthesis and a study on their antibacterial and anticancer properties

inferred← citeshttps://doi.org/10.21203/rs.3.rs-313547/v1openalex-snapshot

Antimicrobial compounds were isolated from the secondary metabolites of endophytic Gordonia in the intestinal tract of Periplaneta americana

inferred← citeshttps://doi.org/10.21203/rs.3.rs-5344759/v1openalex-snapshot

Clinical outcomes of early neonatal sepsis and associated factors in Debre- Tabor comprehensive specialized hospital in Amhara region, Ethiopia

inferred← citeshttps://doi.org/10.2147/dddt.s366423openalex-snapshot

Identification of Drug Combination Therapies for SARS-CoV-2: A Molecular Dynamics Simulations Approach

inferred← citeshttps://doi.org/10.2147/dddt.s405906openalex-snapshot

Knowledge Mapping of Drug Repositioning’s Theme and Development

inferred← citeshttps://doi.org/10.2174/0115748936325300241009051347openalex-snapshot

DSPE: An End-to-End Drug Synergy Combination Prediction Algorithm for Echinococcosis

inferred← citeshttps://doi.org/10.2174/0929867327666200812215852openalex-snapshot

Drug Repurposing: A Strategy for Discovering Inhibitors against Emerging Viral Infections

inferred← citeshttps://doi.org/10.2174/1871520621666211021143255openalex-snapshot

Repurposing Drugs as Novel Triple-negative Breast Cancer Therapeutics

inferred← citeshttps://doi.org/10.2174/18749445-v15-e2206200openalex-snapshot

Drug Development Strategies and Immunological Aspects of SARS-CoV-2

inferred← citeshttps://doi.org/10.2174/9789815123197123010010openalex-snapshot

Drug Repurposing for COVID-19 using Computational Methods

inferred← citeshttps://doi.org/10.22159/ajpcr.2019.v12i6.32706openalex-snapshot

ANTIMICROBIAL ACTIVITIES OF SUCCESSIVE SOLVENT EXTRACTS OF ALBIZIA LEBBECK AND SOLANUM SEAFORTHIANUM AGAINST SOME HUMAN PATHOGENIC MICROORGANISMS

inferred← citeshttps://doi.org/10.22214/ijraset.2024.58345openalex-snapshot

Artificial Intelligence in Antibiotic Discovery Against Superbugs

inferred← citeshttps://doi.org/10.22270/jddt.v15i2.6994openalex-snapshot

In vitro investigation of antifungal efficacy of diclofenac sodium salt against Aspergillus spp. strains causing food spoilage: a drug repurposing approach

inferred← citeshttps://doi.org/10.22377/ijpba.v14i1.2053openalex-snapshot

inferred← citeshttps://doi.org/10.23917/pharmacon.v22i2.13698openalex-snapshot

Drug Repurposing In Modern Drug Discovery: Role of In Silico Study

inferred← citeshttps://doi.org/10.26434/chemrxiv.12032712openalex-snapshot

Screening of Clinically Approved and Investigation Drugs as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike Receptor-Binding Domain Bound with ACE2 COVID19 Target Proteins: A Virtual Drug Repurposing Study

inferred← citeshttps://doi.org/10.26434/chemrxiv.12032712.v1openalex-snapshot

Screening of Clinically Approved and Investigation Drugs as Potential Inhibitors of COVID-19 Main Protease: A Virtual Drug Repurposing Study

inferred← citeshttps://doi.org/10.26434/chemrxiv.12032712.v2openalex-snapshot

inferred← citeshttps://doi.org/10.26599/bdma.2024.9020054openalex-snapshot

MHCLSyn: Multi-View Hypergraph Contrastive Learning for Synergistic Drug Combination Prediction

inferred← citeshttps://doi.org/10.31925/farmacia.2020.6.17openalex-snapshot

SYNTHESIS AND EVALUATION OF THE ANTIMICROBIAL AND ANTIBIOFILM ACTIVITY OF NOVEL DIBENZOTHIEPINES

inferred← citeshttps://doi.org/10.3389/fchem.2026.1842082openalex-snapshot

AI-driven drug reposition for pathogens: a new paradigm in pandemic preparedness

inferred← citeshttps://doi.org/10.3389/fcimb.2018.00438openalex-snapshot

Repurposing Screen Identifies Unconventional Drugs With Activity Against Multidrug Resistant Acinetobacter baumannii

inferred← citeshttps://doi.org/10.3389/fcimb.2019.00067openalex-snapshot

Virtual Screen for Repurposing of Drugs for Candidate Influenza a M2 Ion-Channel Inhibitors

inferred← citeshttps://doi.org/10.3389/fcimb.2019.00193openalex-snapshot

Drug Repurposing to Fight Colistin and Carbapenem-Resistant Bacteria

inferred← citeshttps://doi.org/10.3389/fcimb.2022.926699openalex-snapshot

The repositioned drugs disulfiram/diethyldithiocarbamate combined to benznidazole: Searching for Chagas disease selective therapy, preventing toxicity and drug resistance

inferred← citeshttps://doi.org/10.3389/fmed.2023.1224922openalex-snapshot

Case report: Continuous infusions of ceftazidime-avibactam and aztreonam in combination through elastomeric infusors for 12 weeks for the treatment of bone and joint infections due to metallo-β-lactamase producing Enterobacterales

inferred← citeshttps://doi.org/10.3389/fmicb.2021.652863openalex-snapshot

Emerging Concern for Silver Nanoparticle Resistance in Acinetobacter baumannii and Other Bacteria

inferred← citeshttps://doi.org/10.3389/fmicb.2021.700605openalex-snapshot

Antimicrobial Activities of Alginate and Chitosan Oligosaccharides Against Staphylococcus aureus and Group B Streptococcus

inferred← citeshttps://doi.org/10.3389/fmicb.2024.1396663openalex-snapshot

Fingolimod synergizes and reverses K. pneumoniae resistance to colistin

inferred← citeshttps://doi.org/10.3389/fphar.2020.00248openalex-snapshot

Repurposing Clinical Drugs as AdoMetDC Inhibitors Using the SCAR Strategy

inferred← citeshttps://doi.org/10.3389/fphar.2026.1799614openalex-snapshot

Sodium New Houttuyfonate: a comprehensive review of pharmacological advances in antimicrobial, antitumor, and adjuvanticity effects

inferred← citeshttps://doi.org/10.3390/antibiotics12030499openalex-snapshot

Spiramycin Disarms Pseudomonas aeruginosa without Inhibiting Growth

inferred← citeshttps://doi.org/10.3390/antibiotics8040241openalex-snapshot

Host-Targeted Therapeutics against Multidrug Resistant Intracellular Staphylococcus aureus

showing the first 199 of 248 · page through all 248

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.